Pharma Deals Review, Vol 2009, No 1 (2009)

Font Size:  Small  Medium  Large

S*Bio Signs Two Major Anticancer Deals

Taskin Ahmed

Abstract


S*Bio, based in Singapore concluded two major deals for its anti-cancer drugs during January 2008; one with Onyx Pharmaceuticals for JAK2 inhibitors, SB1578 and SB1518, and the other with Tragara Pharmaceuticals for the oral multikinase inhibitor, SB1317.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.